| NP0333151 | Raufiayunesin A | |  | C21H24N2O4
368.4330 Da 368.17361 Da | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0333152 | Raufiayunesin B | |  | C20H22N2O4
354.4060 Da 354.15796 Da | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) |
|
| NP0333153 | Raufiayunesin C | |  | C22H28N2O5
400.4750 Da 400.19982 Da | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0333157 | 7-Butyl-6,8-dihydroxy-3(R)-pent-9,11-dienylisochroman-1-one | |  | C18H22O4
302.3700 Da 302.15181 Da | | 13C NMR Spectrum (1D, 151 MHz, CD3CN, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CD3CN, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CD3CN, experimental) |
|
| NP0333158 | Persicamidine C | |  | C47H74N2O10
827.1130 Da 826.53435 Da | | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) |
|
| NP0333159 | Persicamidine E | |  | C44H68N2O10
785.0320 Da 784.48740 Da | | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 700 MHz, CD3OD, experimental) |
|
| NP0333160 | Cannabifolin G | |  | C25H28O10
488.4890 Da 488.16825 Da | | 1H NMR Spectrum (1D, simulated) | | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) |
|
| NP0333161 | Cannabifolin H | |  | C23H26O10
462.4510 Da 462.15260 Da | | 1H NMR Spectrum (1D, simulated) | | 13C NMR Spectrum (1D, 126 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 500 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 500 MHz, C2D6OS, experimental) |
|
| NP0333162 | Cannabifolin I | |  | C21H22O11
450.3960 Da 450.11621 Da | | 1H NMR Spectrum (1D, simulated) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|
| NP0333163 | Cannabifolin J | |  | C23H28O10
464.4670 Da 464.16825 Da | | 1H NMR Spectrum (1D, simulated) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|
| NP0333164 | 1,2-di-(4-hydroxybenzoyl)-β-glucopyranose | |  | C23H29O10
465.4750 Da 465.17607 Da | | 1H NMR Spectrum (1D, simulated) | | 13C NMR Spectrum (1D, 126 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 500 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 500 MHz, CD3OD, experimental) |
|
| NP0333166 | 1,6-di-O-p-hydroxybenzoyl-β-D-glucopyranoside | |  | C23H29O10
465.4750 Da 465.17607 Da | |
| NP0333167 | 3α,6β-ditigloyloxytropan-7β-ol | |  | C18H27NO5
337.4160 Da 337.18892 Da | |
| NP0333169 | 1-(7-Methoxy-2-oxo-2H-chromen-8-yl)-3-methyl-1-oxobut-2-en-2-yl (S)-2-methylbutanoate | |  | C20H22O6
358.3900 Da 358.14164 Da | | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 400 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) |
|
| NP0333170 | Murragatin | |  | C15H16O5
276.2880 Da 276.09977 Da | | 1H NMR Spectrum (1D, 400 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) |
|
| NP0333171 | Minutuminolate | |  | C20H22O6
358.3900 Da 358.14164 Da | | 1H NMR Spectrum (1D, 700 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 101 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 400 MHz, CDCl3, experimental) | | 13C NMR Spectrum (1D, 176 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 700 MHz, CDCl3, experimental) |
|
| NP0333173 | Phyllolactone A | |  | C31H48O5
500.7200 Da 500.35017 Da | | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0333174 | Phyllolactone B | |  | C30H46O5
486.6930 Da 486.33452 Da | | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0333175 | Phyllolactone C | |  | C29H44O5
472.6660 Da 472.31887 Da | | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0333176 | Phyllolactone D | |  | C32H48O6
528.7300 Da 528.34509 Da | | 13C NMR Spectrum (1D, 201 MHz, CD3OD, experimental) | | 1H NMR Spectrum (1D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 13C] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) | | [1H, 1H] NMR Spectrum (2D, 800 MHz, CD3OD, experimental) |
|
| NP0333177 | Clavilactone J | |  | C16H16O6
304.2980 Da 304.09469 Da | | 1H NMR Spectrum (1D, simulated) | | 13C NMR Spectrum (1D, 151 MHz, C2D6OS, experimental) | | 1H NMR Spectrum (1D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, C2D6OS, experimental) |
|
| NP0333178 | Clavilactone K | |  | C20H23NO6
373.4050 Da 373.15254 Da | | 1H NMR Spectrum (1D, simulated) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0333179 | Clavipol C | |  | C17H24O5
308.3740 Da 308.16237 Da | | 1H NMR Spectrum (1D, simulated) | | 13C NMR Spectrum (1D, 151 MHz, CDCl3, experimental) | | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) |
|
| NP0333180 | Acetoxytongalide A | |  | C11H14BrClO5
341.5800 Da 339.97131 Da | |
| NP0333181 | Acetoxytongalide B | |  | C11H14Br2O5
386.0360 Da 383.92080 Da | |